Meeting
2018 ASCO Annual Meeting
Population-based study predicting the probability of death resulting from non-small cell lung cancer (NSCLC) and other causes among NSCLC patients with surgery.
Authors
Bo Jia
Department of Thoracic Medical Oncology, Peking University Cancer Hospital & Institute, Beijing, China
Bo Jia , Ziping Wang , Qiwen Zheng , Yuyan Wang , Xinmeng Qi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 36, 2018 (suppl; abstr 8525)
DOI
10.1200/JCO.2018.36.15_suppl.8525
Abstract #
8525
Poster Bd #
131
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2011 ASCO Annual Meeting
Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery.
First Author: S. Senan
Poster
2024 ASCO Breakthrough
Preliminary analysis of PD-1 inhibitors combined with chemotherapy as neoadjuvant therapy for local advanced non-small cell lung cancer (NSCLC).
First Author: Hongru Li
Poster
2023 ASCO Quality Care Symposium
Rates of surgery and adjuvant chemotherapy use in patients with stage IB to IIIA non-small cell lung cancer: A provincial population-based study.
First Author: Yuchen Li
Poster
2022 ASCO Annual Meeting
Dynamic monitoring circulating tumor DNA in plasma samples by PEAC technology for patients with early-stage non–small cell lung cancer after surgery.
First Author: Ning Li